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ABSTRACT
Bacterial conjugation is regulated by two-
component repression comprising the antisense
RNA FinP, and its protein co-factor FinO. FinO
mediates base-pairing of FinP to the 50-untranslated
region (UTR) of traJ mRNA, which leads to transla-
tional inhibition of the transcriptional activator TraJ
and subsequent down regulation of conjugation
genes. Yet, little is known about how FinO binds to
its RNA targets or how this interaction facilitates
FinP and traJ mRNA pairing. Here, we use solution
methods to determine how FinO binds specifically
to its minimal high affinity target, FinP stem–loop II
(SLII), and its complement SLIIc from traJ mRNA.
Ribonuclease footprinting reveals that FinO
contacts the base of the stem and the 30 single-
stranded tails of these RNAs. The phosphorylation
or oxidation of the 30-nucleotide blocks FinO
binding, suggesting FinO binds the 30-hydroxyl of
its RNA targets. The collective results allow the gen-
eration of an energy-minimized model of the FinO–
SLII complex, consistent with small-angle X-ray
scattering data. The repression complex model
was constrained using previously reported cross-
linking data and newly developed footprinting
results. Together, these data lead us to propose a
model of how FinO mediates FinP/traJ mRNA
pairing to down regulate bacterial conjugation.
INTRODUCTION
Plasmid conjugation is a major mechanism of horizontal
gene transfer between bacteria, and is responsible for the
rapid spread of virulence and antibiotic resistance factors
throughout bacterial populations. The study of the
conjugative transfer of F and F-like plasmids in
Escherichia coli has provided important insights into the
mechanisms underlying this process (1,2). Cells newly
infected with many of the plasmids from the F family
are initially competent to express the major plasmid tran-
scriptional unit, the tra operon, and efﬁciently transfer
plasmid to recipient cells. Gradually, however, tra expres-
sion is repressed, and conjugation is attenuated. The initial
burst of conjugation spreads the plasmid throughout a
population. The subsequent repression of the conjugation
machinery likely protects the plasmid-bearing cells from
infection by pili-speciﬁc bacteriophage, and reduces the
metabolic burden of plasmid maintenance.
Repression of conjugation relies on a plasmid-encoded
antisense RNA system called FinOP. The antisense RNA,
FinP, is complementary to the 50-UTR of traJ, the tran-
scriptional activator of the tra operon (3–6) (Figure 1A
and B). Binding of FinP to the traJ mRNA occludes the
ribosomal binding site, inhibiting traJ translation and pre-
venting tra operon expression via H-NS de-silencing (7).
FinP alone, however, is unable to repress conjugation, in
part because it is rapidly degraded by RNaseE, a compo-
nent of the E. coli RNA degradosome (8,9). FinP requires
a second plasmid factor, the FinO protein, which binds
FinP and stabilizes it against degradation (8,10). FinO
also binds the traJ 50-UTR, and facilitates FinP–traJ
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to 1000-fold.
FinO recognizes multiple stem–loop structures in both
the FinP and traJ 50-UTR RNAs, binding with highest
afﬁnity to FinP SLII (11). Stem–loop recognition is inde-
pendent of the precise RNA sequence, but requires 50
and 30single-stranded tails adjacent to the duplex stem.
The FinO protein adopts a novel protein fold with an
extended a-helix and an unstructured N-terminal region
(12) (Figure 1D). The C-terminal globular domain,
FinO45–186, which lacks the unstructured region and
much of the extended a-helix, comprises the core RNA
binding domain (12,13). Site-speciﬁc protein–RNA
cross-linking studies have indicated that residues on one
face of the globular domain, as well as near the N-terminal
tip of the extended a-helix, contact SLII (14).
Perhaps the most intriguing aspect of FinO function is
its ability to facilitate FinP–traJ RNA pairing (10,15,16).
In spite of the perfect complementarities of these RNAs,
duplexing is extremely slow in the absence of FinO
because of the signiﬁcant energy barriers posed by the
highly stable internal stem–loops present in both RNAs.
FinO not only facilitates duplexing, but also promotes
strand exchange between a minimal SLII-like duplex sub-
strate and a complementary single strand (15). This
suggests that FinO may act by destabilizing the internal
duplex structure, thereby lowering the free-energy barrier
to intermolecular base-pairing interactions. Deletion
analyses reveal that this activity requires the N-terminal
disordered region as well as the N-terminus of the
extended helix. A solvent-exposed tryptophan residue at
the tip of the exposed N-terminal helix (Trp36) appears to
be the most critical single residue for both RNA duplexing
and strand exchange activities (15).
In this article, we used solution techniques to develop a
structural model for the interaction between FinO and
minimal, high-afﬁnity target RNAs. Ribonuclease foot-
printing reveals that wild-type FinO and the truncation
mutants, FinO33–186 W36A and FinO45–186, all contact
FinP SLII and traJ SLIIc RNAs in a similar manner
involving the base of the duplex stem and the 30 single-
stranded tail. FinO binding is blocked by phosphorylation
of the 30-end of the RNA, or oxidation of the 30-ribose,
suggesting a free 30-hydroxyl group is essential for FinO
binding. A complex of FinO45–186 with SLII was modeled
by docking the semi-ﬂexible protein and RNA structures
in an automated, energy-minimizing procedure employing
distance restraints deﬁned directly from our biochemical
data. The model compared favorably with small-angle
X-ray solution scattering data of the same complex.
These data and the structural model were used to
explore the relationship between FinO binding and its
RNA chaperone activity.
MATERIALS AND METHODS
Cloning of FinO constructs
FinO constructs were cloned using Gateway Technology
(Invitrogen) and the overlap extension PCR technique to
introduce mutations (17). Forward attB PCR primers
(Integrated DNA technologies) were designed to have
the necessary homologous recombination sites and a
cleavage site for Prescission protease (GE Healthcare).
The sequences for the forward primers are: FinO WT
Fwd (50-GGG GAC AAG TTT GTA CAA AAA AGC
AGG CTT CCT GGA AGT TCT GTT CCA GGG GCC
CAT GAC AGA GCA GAA ACG ACC GGT A-30),
FinO 33W36A Fwd (50-GGG GAC AAG TTT GTA
CAA AAA AGC AGG CTT CCT GGA AGT TCT
GTT CCA GGG GCC CCC ACC AAA AGC GAA
GGT GAA A-30), FinO 45 Fwd (50-GGG GAC AAG
TTT GTA CAA AAA AGC AGG CTT CCT GGA
AGT TCT GTT CCA GGG GCC CGA GAA GGC
TGC CCG GGA AGC AGA G-30). The sequence for
the reverse primer is: FinO 186 Rev (50-GGG GAC
CAC TTT GTA CAA GAA AGC TGG GTC CTA
TCA TTG TTC ATC AAG CAC GGC CTG AAG
TTC-30). The primers were used to PCR off a
pGEX-KG plasmid containing the FinO 1–186 gene
(13). The ampliﬁed inserts were recombined into
pDONR 201 and transferred to the pDEST-15 expression
plasmid containing the glutathione-S-transferase gene.
The sequence of the expression clones were veriﬁed for
the correct FinO sequence by DNA sequencing
(Molecular Biology Services Unit, University of Alberta
Department of Biological Sciences).
Expression and puriﬁcation of FinO constructs
Expression of each FinO-GST construct was described
previously (13). Gel ﬁltration chromatography was used
to further purify the FinO constructs. Fractions contain-
ing FinO were concentrated and loaded onto a Superdex
75 26/60 gel-ﬁltration column (GE Healthcare) which was
equilibrated in 50mM HEPES pH 7, 200mM NaCl, 1mM
EDTA, 5mM Tris(2-carboxyethyl) phosphine hydro-
chloride (TCEP) (Sigma-Aldrich). Puriﬁed FinO was
concentrated to the desired concentration and protein
concentrations were calculated using extinction coefﬁ-
cients at 280nm determined experimentally by amino
acid analysis (Alberta Peptide Institute): FinO1–186 WT
(27872M
 1cm
 1), FinO33–186 W36A (21263M
 1cm
 1)
and FinO45–186 (20469M
 1cm
 1).
Preparation and labeling of RNA constructs for
electrophoretic mobility shift and RNase
footprinting experiments
SLII and SLIIc constructs (sequences shown in bold in
Figure 1B and A) were chemically synthesized using an
Applied Biosystems DNA synthesizer which was
modiﬁed for RNA synthesis using Dharmacon 20 ACE
chemistry (18). The 50-end-labeled RNAs were labeled
with g
32P-ATP (6000Ci/mmol, Perkin Elmer) and T4
polynucleotide kinase (New England Biolabs). The
30-end-labeled RNAs were labeled with 30,50-cytidine
[50-
32P] diphosphate (pCp) (Perkin Elmer) and T4 RNA
Ligase I (New England Biolabs). Both labeling reactions
were puriﬁed using denaturing gel electrophoresis. The
50-end-labeled pellets were resuspended in 1 TE pH
7.5, 10mM NaCl. The 30-end-labeled pellets were resus-
pended in 50ml of ddH2O. An additional T4 kinase
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Figure 1. Overview of constructs used in the study. (A and B) The secondary structures of traJ mRNA and FinP, respectively. The ribosomal
binding site and start codon of traJ mRNA are boxed. The derivative RNAs of focus, SLIIc and SLII, are shown in bold and numbered accordingly.
(C) The secondary structure SLII LV1 RNA, used to form a complex with the FinO45–186 in the SAXS experiments. SLII LV1 deviates from
wild-type SLII in its loop region, which is shown in bold. (D) The crystal structure of FinO26–186 highlighting the protein constructs used in the
experiments. The W36A mutation is shown as a ball on the structure. The N-terminal 32 amino acids were not observed due to disorder in the
structure and are drawn in (dashed section). Below is a scaled linear representation of the primary structure of FinO showing where each construct
begins. The shades of gray correspond to the crystal structure coloring. (E) A representative 8% native PAGE demonstrating each of the FinO
constructs in a 1:1 molar complex with 50-
32P-SLII.
4452 Nucleic Acids Research, 2011,Vol.39, No. 10dephosphorylation step was needed to remove the
30-phosphate from the added cytidine of the 30-end-labeled
RNAs which prevented binding of the FinO constructs.
The 30-dephosphorylated end-labeled RNAs were resus-
pended in 1 TE pH 7.5, 10mM NaCl. RNAs containing
a2 0,30 dialdehyde terminal ribose were generated by treat-
ment of the 30 dephosphorylated RNA with 10mM
NaIO4. For each periodate reaction, 1ml of dephosphoryl-
ated, annealed,
32P-SLII was added to 99mlo f1 0 m M
NaIO4. The reactions were incubated at 4 C for 40min
in the dark followed by ethanol precipitation. The pellets
were washed and resuspended in 7ml ddH2O. The
periodate-treated
32P-SLII resuspensions were then
added to 1ml1 0  structure buffer (500mM Tris–HCl
pH 7.5, 1M NaCl, 100mM MgCl2), 1ml of 2mg/ml
tRNA, and 1ml1 0 mM FinO (wild-type, 33-186 W36A
or 45-186) or 1  structure buffer for the no protein
reaction. Parallel binding reactions were performed for
untreated, annealed, dephosphorylated
32P-SLII RNA
using 1ml RNA, 1ml1 0   structure buffer, 1ml of 2mg/
ml tRNA, 1ml1 0mM FinO (wild-type, 33–186 W36A, or
45–186) or 1  structure buffer for the no protein reaction,
and 7ml ddH2O. All 10ml binding reactions were
incubated at 4 C for 30min before adding 10ml of 20%
glycerol and loading onto an 8% native polyacrylamide
gel, equilibrated with 1  tris–glycine, pH 8.0 at 4 C. Prior
to use in the footprinting experiments, all labeled RNA
stocks were annealed by heating to 95 C for 1min
followed by slow cooling to room temperature.
Electrophoretic mobility shift experiments were carried
out as described previously (15).
RNase footprinting
Native electrophoretic mobility shift assays were used to
ﬁnd 1:1 molar ratio FinO–RNA complexes prior to foot-
printing experiments. The binding reactions for the RNase
footprinting experiments were performed in 14ml reac-
tions: 1.5mlo f1 0   structure buffer (500mM Tris–HCl
pH 7.5, 1 M NaCl, 100mM MgCl2), 1.5ml of puriﬁed,
annealed 50 or 30-
32P-SLII or SLIIc (in 10mM Tris–HCl
pH 7.5, 10mM NaCl, 1mM EDTA), 1.5ml of protein
sample (at 10  ﬁnal concentration in 50mM HEPES
pH 7, 200mM NaCl, 1mM EDTA, 5mM TCEP), 1.5ml
of 2mg/mL tRNA (Ambion), and 8ml ddH2O. Reactions
were incubated on ice for 30min and aliquots of 5ml of the
reaction was removed and added to 5ml of 20% glycerol
and loaded onto an 8% native gel to assay binding. One
microliter of RNase V1 or I (at the appropriate concen-
tration; see below) was added to the remaining 9ml of the
binding reaction. RNase cleavage experiments were
incubated at 4 C for 1h and stopped immediately with
120ml of 0.3M NaOAc pH 5.3 and 130m l of phenol/
chloroform/IAA. Samples were then chloroform extracted
and ethanol precipitated. Pellets were resuspended in 4mL
of formamide gel load buffer and loaded on a 15%
urea-denaturing sequencing gel. Gels were exposed over-
night and quantitated using ImageQuant software (GE
Healthcare). To determine the optimal amount of
RNase V1 or I to add for the footprinting assays, we per-
formed cleavage assays with end-labeled SLII or SLIIc (at
the same concentration as the footprinting experiments)
where the concentration of RNase V1 or I was increased
until non-speciﬁc cleavages resulted. The reactions were
incubated at the same temperature and length of time as
the footprinting experiments. A ﬁnal RNase V1 concen-
tration of 0.001U/ml and RNase I concentration of
0.01U/ml gave speciﬁc cleavages with an adequate signal
to noise.
We used two different methods to assign the RNase V1
cleavage products which, due to a 30-OH, run slower on a
denaturing gel. First, for the 50-
32P SLII RNase V1
cleavage assays, we chemically synthesized short RNA
markers which had the same sequence as SLII and had a
30-OH. SLII markers were 10 (50-GACAGUCGAU-30)
and 15 (50-GACAGUCGAUGCAGG-30) nucleotides in
length (Figure 2, left). The oligomers were synthesized,
puriﬁed and labeled in the same manner as SLII and
SLIIc (see above). The other method used T4 polynucleo-
tide kinase, in the absence of ATP, to remove the
30-phosphate from the RNase T1 and alkaline hydrolysis
products (19).
To quantify the footprinting data, we ﬁrst normalized
the total counts in each FinO–RNA complex lane to the
total counts of the ‘No Protein’ lane to account for lane
loading discrepancies. Then for each band of interest, rep-
resenting a position in the RNA, the fraction (f) of the total
counts for that band was calculated (fp, i) where p is a
FinO–RNA complex (either FinO, FinO33–186 W36A or
FinO45–186), and i is the nucleotide position of the RNA.
We also determined the fraction of the total counts for the
‘No Protein’ sample (fnp,i) at this position. Finally, we
divide fnp,i by fp,i to get the protection factor which is
deﬁned as the magnitude by which the RNA was protected
from RNase cleavage by each FinO. For each RNase
cleavage experiment, two independent reactions were
performed and loaded onto the same gel. The values in
Figures 2B and 3B are an average of these two independent
reactions. We decided on a protection value of two or
greater to represent a signiﬁcant footprint. This is shown
in the ﬁgures as a horizontal rule across the graph.
Preparation of samples for SAXS experiments
For the small-angle X-ray scattering (SAXS) experiments,
the FinO45–186 construct was the same as for the RNase
footprinting studies. We used a full-length SLII construct
with a different loop sequence denoted SLII LV1 (the
sequence is shown in Figure 1C). The RNA was chem-
ically synthesized and gel puriﬁed using the same proced-
ures as for SLII and SLIIc (above). Precipitated RNA
samples were resuspended in 1  TE pH 7.5, 10mM
NaCl at the appropriate concentration and quantiﬁed
using extinction coefﬁcients determined by an online
calculator (Ambion).
SAXS data collection and analysis
SAXS data were collected at beamline 12.3.1 of the
Advance Light Source, Lawrence Berkeley National
Laboratory on a MAR165 detector (20,21), at a 1.6m
sample to detector distance and a wavelength of 1.12A ˚ .
The hutch temperature was maintained at 17 C during
Nucleic Acids Research, 2011,Vol.39, No. 10 4453data collection. Solvent-only exposures of 7 and 70s for
background subtraction were taken from the dialysis
supernatant of each construct before and after each
sample data collection. A sequence of consecutive expos-
ures lasting 7, 7, 70 and 7s were recorded for each sample
and the appropriate background exposure subtracted and
circularly averaged using the program OGRE2 provided
at the beamline. No sign of radiation-induced aggregation
was observed in the consecutive exposures. The program
AUTORG (22) was used to check the linearity of log(I(s))
versus s
2 at low angle (s<0.05A ˚  1) and conﬁrm the
absence of aggregation.
Protein–RNA docking
A model of SLII including the 50- and 30-tails was initially
constructed based on the NMR structure of the initiator
tRNA anti-codon loop from yeast, a 21-nt RNA stem–
loop (RCSB accession code 1SZY) (23). The nucleotides
were mutated to correspond to the sequence of SLII using
COOT (24) and the stem–loop geometry-regularized in
CNS (25). A model for FinO45–186 was derived by
removing residues 33–44 from the crystal structure
(RCSB accession code 1DVO). The docking of SLII to
FinO45–186 was performed using the chemical
restraint-driven program HADDOCK2.0 (26,27). On the
protein, active ambiguous air restraints (AIRs) were
deﬁned as residues found to form chemical cross-links
with the RNA as determined in Ghetu et al. (14) (Lys46,
Lys81, Arg121, Lys125, Arg165 and Lys176). Passive
AIRs on SLII were those nucleotides determined by ribo-
nuclease footprinting to be protected in the complex,
namely nucleotides 7, 8 and 36–45 (numbering as SLII
in Figure 7A). No passive AIRS were deﬁned for FinO,
and no active AIRs were deﬁned for SLII. Default settings
were used for most HADDOCK parameters. No AIRs
were randomly removed during separate docking trials.
The stem of SLII was further geometry-restrained to be
an A-form helix with Watson–Crick base pairing. The 50-
and 30-tails of SLII were deﬁned as both semi- and fully
ﬂexible regions. Semi-ﬂexible protein residues were auto-
matically chosen by HADDOCK if they were within 5.0A ˚
of the RNA. A control experiment was carried out, in
which 2500 docking trials used randomly deﬁned AIRs
with random removal of 50% of AIRs per trial.
Filtering of all docked models against the SAXS data
used the program CRYSOL (28) to calculate theoretical
scattering curves and obtain values of RG and Dmax for the
models. The theoretical scattering curves were ﬁt to the
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Figure 2. RNase V1 cleavage of 50- and 30-end-labeled SLII in the absence and presence of various FinO constructs. (A) 15% urea-denaturing
polyacrylamide gels showing the products of RNase V1 (0.001U/ml ﬁnal concentration) cleavage reactions. M10 and M15 are synthesized SLII RNA
markers of 10 and 15 nucleotides in length (see ‘Materials and Methods’ section). The lanes OH and T1 represent the alkaline hydrolysis and RNase
T1 cleavage of denatured SLII, respectively. SLII nucleotide positions are indicated at the right of the gels. Large and small arrowheads indicate
major or minor cleavages by RNase V1 in the presence of FinO. Vertical brackets represent signiﬁcant footprints on SLII RNA resulting from FinO
protection of SLII from RNase V1 attack. (B) Bar graphs showing the quantiﬁcation of the footprint areas of the gels in (A). The left axis shows the
degree of FinO protection from RNase V1 relative to the ‘No protein’ reaction. In black is FinO1–186 WT, white is FinO33–186 W36A, and in gray is
FinO45–186. Data above the horizontal dashed rule in each graph represent signiﬁcant protection ( 2-fold) by FinO. The black bars below the x-axis
highlight the footprint. The shift in the footprint when 50- and 30-end-labeling are compared is likely due to the effect of adding pCp to the 30-end of
the RNA when 30-end-labeling. In Figure 6, we demonstrate that this subtly alters protein binding.
4454 Nucleic Acids Research, 2011,Vol.39, No. 10experimental SAXS data using CRYSOL in the range
0<s<0.3A ˚  1 to provide a goodness-of-ﬁt value,  
2.
The top 250 models, ordered on ﬁt to the data, were sub-
jected to pair-wise cluster analysis based on structural
similarity. The RMSD cutoff of 13A ˚ was chosen as
small as possible while still providing enough models in
a cluster to be meaningful. The ﬁve clusters obtained had
their members aligned using the maximum-likelihood
superpositioning program THESEUS (29).
Calculation of electrostatic potentials
Electrostatic potentials were calculated using the Adaptive
Poisson–Boltzmann Solver (30) and the PARSE force
ﬁeld. PDB2PQR was used to prepare the RCSB ﬁle
1DVO for this calculation (31).
RESULTS
FinO binds to the lower duplex region of SLII and SLIIc
In order to facilitate FinP–traJ mRNA pairing, FinO
must ﬁrst bind to its target RNAs. Previous studies have
shown that FinO binds speciﬁcally and with high afﬁnity
to the SLII and SLIIc domains of FinP and traJ mRNAs,
respectively (Figure 1A and B) (11,13). We used enzymatic
footprinting experiments to determine which areas of these
stem–loop target RNAs are contacted by FinO. We
compared interactions made by full length FinO, with
those of two mutants in which RNA strand exchange
and duplexing have been compromised (Figure 1D).
FinO33–186 W36A lacks part of the N-terminal region
required for RNA duplexing/strand exchange, and also
bears a substitution at the critical Trp36 residue. This
variant binds RNA with a signiﬁcantly enhanced afﬁnity,
butitsstrandexchangeandduplexingactivitiesarereduced
compared to wild-type FinO. FinO45–186 corresponds to
the core RNA binding domain and binds SLII with a
20-fold higher afﬁnity than wild-type FinO, but has no
detectable strand exchange or RNA duplexing activity.
RNase V1 (32) was used to map interactions between
the various FinO proteins and double-stranded or stacked
single-stranded regions of RNA targets. SLII and SLIIc
RNAs were radiolabeled at the 50-o r3 0-end and subjected
to limited RNase V1 digestion alone or in complex with
FinO at a 1:1 molar ratio. Native gel electrophoresis was
used to ensure complex formation under these conditions
(Figure 1E). The results of the RNase V1 cleavage experi-
ments with 50 and 30-end-labeled SLII are shown in
Figure 2A. In the absence of FinO, strong cleavage was
observed on both strands of the duplex stem, consistent
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from FinO protection of SLIIc from RNase V1 attack. The asterisk at position C10 marks very weak protection of the lower stem at the 50-end of
SLIIc. (B) Bar graphs showing the quantiﬁcation of the footprint areas of the gels in (A). The left axis shows the degree of FinO protection from
RNase V1 relative to the ‘No protein’ reaction. In black is FinO1–186 WT, white is FinO33–186 W36A, and in gray is FinO45–186. Data above the
horizontal dashed rule in each graph represent signiﬁcant protection ( 2-fold) by FinO. The black bars below the x-axis highlight the footprint.
Nucleic Acids Research, 2011,Vol.39, No. 10 4455with previous ribonuclease mapping carried out on intact
FinP (33). FinO binding protected residues G32-C39 on
50-
32P-SLII (left gel) and residues A34-C39 on 30-
32P-SLII
(right gel) corresponding to the lower 30-portion of the
SLII double-stranded stem region. A minor footprint
was observed on the 50-
32P-SLII gel at positions C7 and
G8, which maps to the lower 50-portion of the SLII stem.
Essentially identical protection patterns were observed for
all three FinO constructs. Quantiﬁcation of the footprint
regions is shown in Figure 2B. For this study, we chose
protection values greater than or equal to 2-fold relative to
the ‘No Protein’ sample as signiﬁcant (see ‘Materials and
Methods’ section).
An area of intense RNase V1 cleavage was observed on
the 50-side of the SLII stem proximal to the loop (residues
G11–G14, with minor cleavages at U10 and G15–G16) in
the presence of all FinO constructs. Minor cleavages also
were observed on the 30-side of the SLII stem proximal to
the loop (C26 to G32). Taken together, the results suggest
that FinO contacts the end of the SLII duplex proximal to
the single-stranded tails but does not contact the region of
the stem proximal to the loop.
The RNase V1 cleavage results for SLIIc were similar
for SLII (Figure 3). FinO protected the lower portion of
the 30-side of the stem of SLIIc from RNase V1 cleavage at
positions C32-U37 on 50-
32P-SLIIc and A36-A40 on
30-
32P-SLIIc. Like SLII, there appeared to be a very
weak protection of the lower stem at the 50-end of SLIIc
at position C10 (marked by an asterisk in Figure 3A, left
gel). Both 50- and 30-end-labeled SLIIc gels have strong
RNase V1 cleavages at the upper portion of the stem on
the 50 side. These cleavages at positions C14 to G18, with
weaker cleavages nearby, were observed in the presence
of all FinO constructs. The upper 30 portion of the
SLIIc stem had weaker cleavages from C28 to G34. The
results indicate that SLIIc binds to FinO and its deriva-
tives in a similar fashion as SLII, with the interaction
occurring at the lower part of the SLIIc stem region,
leaving the upper half of the stem exposed to cleavage
by RNase V1.
FinO does not bind to the loop region of its target RNAs
It was previously shown that deletion of the seven nucleo-
tide loop from SLII does not affect the afﬁnity of FinO
binding, suggesting the loop plays little if any role in
speciﬁc, high afﬁnity interactions with FinO (15). We
used RNase I (34) footprinting to directly probe for inter-
actions between FinO and single-stranded areas of SLII or
SLIIc. Figure 4 shows the results for the limited RNase I
digestion of SLII and SLIIc both free, and in a 1:1
complex with the three FinO constructs. For both
RNAs, intense cleavage was observed, as expected, at
the single-stranded loop regions, and FinO binding con-
sistently resulted in a signiﬁcant enhancement in this
cleavage.
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Figure 4. Limited RNase I digestion of 50- and 30-end-labeled SLII and SLIIc in the absence and presence of various FinO constructs. Products of
the RNase I (0.01U/ml ﬁnal concentration) cleavage reactions were resolved on 15% urea-denaturing polyacrylamide gels. The radiolabeled RNA
construct is noted below each of the gels. The lanes OH and T1 represent the alkaline hydrolysis and RNase T1 cleavage of denatured SLII or SLIIc,
respectively. The RNA nucleotide positions are indicated at the left of the gels. Large and small arrowheads indicate major or minor cleavages by
RNase I in the presence of FinO while the vertical bracket indicates protection from RNase I.
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degradation and enhances cleavage of the 50-tail of SLIIc
It has been shown by electrophoretic mobility shift assays
that a 30 single-stranded tail of at least six nucleotides on
SLII (and FinP) is required to bind FinO (11). Removing
the tail in its entirety led to a 5.5-fold decrease in afﬁnity
for FinO-GST. To a much lesser extent, removing the four
nucleotide 50-tail of SLII (spacer between SLI and SLII in
FinP) led to a modest 1.3-fold decrease in afﬁnity, and
removal of both tails decreased afﬁnity for FinO by
nearly 14-fold. We used RNase I footprinting to test for
interactions between FinO and the 50- and 30-tails. The
50-
32P-labeled SLII cleavage gel in Figure 4 suggests that
protection of the 30-tail does occur.
To more clearly assess this protection, we carried out
RNase I footprinting experiments at a much higher RNase
I concentration, to enhance cleavage of the 30-tail and
reduce the amount of full-length RNA which would other-
wise obscure the footprint. The clearest results were
obtained for 50-labeled SLII RNA (Figure 5A). Under
these conditions, the 30-tail was completely removed in
the absence of FinO. Dramatic protection was observed
with increasing FinO concentrations, suggesting a strong
interaction between FinO and the 30-tail. Less dramatic
but signiﬁcant protection was observed for the 30-tail of
SLIIc (Figure 5B). Similar results were also observed for
FinO33–186 W36A and FinO45–186 (data not shown).
In contrast, the 50-tails of SLII and SLIIc did not
appear to be protected by FinO. This was most clearly
demonstrated for the SLIIc construct (Figure 5C). Here,
modest cleavage of the 50-tail was observed in the absence
of FinO, however, binding of any of the FinO variants
resulted in a more signiﬁcant cleavage of the 50-tail. This
suggests that FinO binding frees the 50-tail of SLIIc for
attack by RNase I. We were unable to detect RNase I
cleavage at the shorter, four nucleotide 50-tail of SLII
(Figure 5D). A summary of the RNase I and RNase VI
cleavage data for SLII and SLIIc is shown in Figure 7A.
FinO selectively binds to the 30-hydroxyl group of the
30-tail of SLII
To further test the nature of recognition of the SLII 30-tail
by FinO, we created a version of SLII in which
30,50-cytidine diphosphate (pCp) was appended at the
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Figure 5. RNase I overdigestion of 50- and 30-end-labeled SLII and SLIIc in absence and presence of various FinO constructs. In all experiments, the
RNAs were digested with RNase I at a ﬁnal concentration of 0.1U/ml. (Ai) A 8% native EMSA showing binding reactions of 50-
32P-SLII with
increasing amounts of wild-type FinO before the addition of RNase I. The ﬁnal concentration of FinO WT in micromolar in each reaction is
indicated on top of the gel. (Aii) Slice from a 15% urea-denaturing gel showing the products of the RNase I digest of 50-
32P-SLII at the 30-end in the
presence of increasing amounts of FinO. The lanes correspond to the binding reactions in (Ai). The lanes OH and T1 represent the alkaline
hydrolysis and RNase T1 cleavage of denatured 50-
32P-SLII, respectively. SLII nucleotide positions are indicated at the right of the gel. (B) Slice
from a 15% urea-denaturing gel showing the products of the RNase I digest of 50-
32P-SLIIc at the 30-end in the absence and presence of various
FinO constructs. Nucleotide position G39 is indicated next to the gel. (C) Slice from a 15% urea-denaturing gel showing the products of the RNase I
digest of 30-
32P-SLIIc at the 50-end in the absence and presence of various FinO constructs. SLIIc nucleotide positions are indicated next to the gel.
(D) Slice from a 15% urea-denaturing gel showing the products of the RNase I digest of 30-
32P-SLII at the 50-end in the absence and presence of
various FinO constructs. Nucleotide position G5 is indicated at the right of the gel. For experiments in (B–D), a 1:1 molar ratio FinO-RNA complex
was formed prior to exposure to RNase I.
Nucleic Acids Research, 2011,Vol.39, No. 10 445730-end using T4 RNA ligase I. Intriguingly, none of the
FinO constructs bound this RNA in electrophoretic
mobility shift assays; however, binding could be restored
by treatment of this RNA with T4 kinase/phosphatase to
remove the terminal 30-phosphate (Figure 6). To further
probe the speciﬁcity for the RNA 30-hydroxyl group, we
next treated the RNA with NaIO4, which selectively
oxidizes the 30 ribose sugar to a 20,30 dialdehyde (35).
This treatment abrogated FinO binding, further demons-
trating the selective recognition of the 30-hydroxyl group
by FinO.
An energy-minimized, biochemical knowledge-driven model
of the FinO45–186–SLII complex
High resolution structural information for FinO–RNA
complexes has been difﬁcult to obtain using either X-ray
crystallographic or NMR approaches (D.C.A., R.A.E.
and J.N.M.G., unpublished data). In the absence of such
information, we turned to small-angle X-ray scattering
(SAXS) to provide structural information to help to
deﬁne FinO–RNA interactions, as it is suitable to deﬁne
ﬂexible and dynamic complexes (36). We decided to focus
on complexes between FinO45-186 and the minimal SLII
RNA target for three reasons. First, the footprinting
results described above indicate that FinO45–186 contacts
the same regions within stem-loop RNA targets as
full-length FinO. Second, FinO45–186 is more soluble and
less prone to aggregation than the larger FinO constructs,
and therefore is more appropriate for SAXS measure-
ments. Third, the fact that FinO45–186 binds SLII with
 20-fold higher afﬁnity than full-length FinO helps
ensure that the experimental sample is fully bound under
the SAXS solution conditions and does not contain a sig-
niﬁcant fraction of unbound components. SAXS data
were collected at the SIBYLS beamline at the Advanced
Light Source on FinO45–186 with the minimal SLII RNA
target. Analysis was consistent with complex formation.
In order to present a rigorous structural model of the
FinO45–186–SLII interaction, we docked existing X-ray
crystal structures of the individual components in a re-
strained energy-minimization procedure. The restraints
were derived from biochemical information presented
here and in previous work (14). A number of spatially
different models resulted, all consistent with the input
restraints. These models were then further ﬁltered based
on their agreement to the solution scattering proﬁle of the
FinO45–186–SLII complex. A single orientation of the
RNA stem–loop docked on FinO agreed with both the bio-
chemical and SAXS data. The restrained energy minimiza-
tion was carried out using the program HADDOCK
(26,27).
Docking in HADDOCK is a multi-step procedure con-
sisting of rigid-body docking by energy minimization,
torsion-angle reﬁnement of residues or nucleotides
involved in the docking interface, and a ﬁnal Cartesian
dynamics reﬁnement in water. The energy minimization
is constrained by chemical distance restraints called
AIRs. AIRs are deﬁned by the user from knowledge
derived from biochemical or biophysical experiments
about the docking components and their interactions.
We have used a combination of site-directed protein–
RNA cross-linking (14) and RNA footprinting (this
work) to deﬁne AIRs between the protein and the RNA.
The RNA footprinting results deﬁne regions of the RNA
that are protected from ribonuclease digestion by FinO
and are therefore likely involved in, or adjacent to, the
protein–RNA interface. The protein–RNA cross-linking
data deﬁnes which regions of the protein are in close
enough proximity to the RNA to form a chemical
cross-link. The crosslinker used, azidophenacyl bromide,
reacts non-speciﬁcally with RNA within a 10A ˚ radius. In
HADDOCK, two types of AIRs are formally deﬁned,
active and passive. Active restraints are between residues
shown experimentally to be involved in the interaction and
have a solvent-exposed surface area of >50%. Passive
restraints are between similarly solvent-exposed residues
that are direct neighbors of active residues. Distance
restraints during the energy-minimization are applied
between pairs of residues being either active–active or
active–passive, but not passive–passive combinations.
Six protein residues showed appreciable cross-linking to
the RNA and were assigned as active AIRs on the protein.
Notably, Arg121 and Lys125, both part of a positively
charged patch on one side of the base of FinO, exhibited
signiﬁcantly stronger crosslinks than Lys46, Lys81,
Arg165 or Lys176. Nucleotides of SLII protected from
No Protein
FinO
33-186 W36A
45-186
2’,3’ cis-diol
No Protein
FinO
33-186 W36A
45-186
2’,3’ dialdehyde 3’ phosphate
T4 kinase/
phosphatase NaIO4
FinO 33-186 W36A 45-186
NP
FinO-SLII
32P-SLII
AB C
Figure 6. FinO binding to SLII requires a terminal 30-OH on the 30-tail of SLII. Native gels (8%) of binding reactions between FinO constructs and
SLII RNA derivatives. (A) FinO does not bind SLII RNA containing a 30,50-cytidine diphosphate 30-terminus. T4 RNA ligase I was used to ligate
30,50-cytidine [50-
32P] disphosphate (pCp) to the 30-tail resulting in a 30-phosphate. NP, no protein. Triangles represent increasing concentrations of
FinO or the indicated mutants: 0.25, 0.5, 1, 2.5, 5 and 10mM. The positions of free
32P-SLII and the FinO-
32P-SLII are noted by arrows. (B)
Treatment of SLII RNA containing a 30,50-cytidine diphosphate 30-terminus to give a 20,30 cis-diol (30-hydroxyl) restores FinO binding. (C) Oxidation
of SLII with sodium periodate to give a 20,30 dialdehyde reduces binding afﬁnity. The protein concentrations were 1mM in each of the binding
reactions in B and C.
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(7,8,36–45, Figure 7A), were assigned as passive AIRs.
HADDOCK was used to generate 2500 models
sampling a subset of the complex’s conformation space
deﬁned by the biochemical information encoded in the
form of ambiguous interaction restraints (see ‘Materials
and Methods’ section). RNA duplexes were primarily re-
stricted to the positively charged face of the protein and
oriented with the 50-and 30-tails contacting the base of
FinO with the loop exposed into the solvent, orientations
largely constrained by the distance restraints. The models
sample a broad selection of size and shape, with RG
ranging from 23.0 to 33.9A ˚ . The mean ﬁt to the data
for this model set had a  
2 of 11.5 with a best ﬁt of 3.4.
A further improvement in ﬁt could be obtained by
allowing those residues determined to be ﬂexible by
normal mode analysis of FinO45–186, namely residues
45–64 of the N-terminal a-helix, to be fully ﬂexible
during the docking. This ﬂexible model set had a mean
and best ﬁt  
2 of 9.7 and 2.3, respectively. The full model
set is represented in Supplementary Figure 1 along with a
subset of the best 50 models ordered on  
2.
For comparison, HADDOCK was run using randomly
selected AIRs between residues and nucleotides containing
>20% relative accessibility to generate 2500 models. This
random-AIR model set had a mean  
2 of 17.5, signiﬁcant-
ly worse than that of the restrained model set, with the
single best-ﬁt to the experimental scattering of 2.1.
Although this best-ﬁt randomly restrained model slightly
improves the ﬁt to the SAXS data relative to the best-ﬁt
restrained model, inspection shows a poor ﬁt to the bio-
chemical data. The best 250 RNA–protein complex
models, ordered on  
2 were subjected to RMSD-based
pair-wise cluster analysis. Five clusters (Figure 8) met
the criteria of having a pair-wise RMSD cutoff less than
13A ˚ and containing at least six members. In every case,
the RNA docked to the side of FinO containing the posi-
tively charged patch and residues Arg121, Lys125 and
Arg165. Alignment of the stem–loop was also consistent
amongst all clusters with the base of the RNA closer to the
globular portion of FinO and the stem-loop generally co-
incident with the N-terminal helical extension. A represen-
tative model from one of these clusters was chosen to
illustrate the satisfaction of a number of the programmed
distance restraints and the general orientation of the RNA
stem (Figure 9A) while still providing a reasonable ﬁt to
the SAXS data (Figure 9B). Nucleotides C7 and G8 are
partially buried against the N-terminal a-helix of FinO
and the 30-tail extends along the positively charged face
of FinO within contact distance of residues Arg121,
Lys125 and Arg165. The ﬁt of this particular model to
the experimental data,  
2 of 4.2, is comparable to the
mean  
2 of 4.6 for all 39 models in the ﬁve clusters.
DISCUSSION
FinO binds to SLII and SLIIc at the lower half of the
duplex and the 30-tail
Our footprinting results indicate that FinO binds its target
RNAs through recognition of single strand–duplex RNA
junctions. This interaction is asymmetric; that is, the 30
single strand and 30 side of the duplex is contacted more
strongly by the protein than the 50 single-stranded tail or
the 50 side of the duplex. While these interactions were
clearly evident in ribonuclease footprinting experiments,
we were unable to detect any interactions using the
chemical probes diethylpyrocarbonate (DEPC), dimethyl-
sulphate (DMS), or hydroxyl radical (data not shown).
This suggests that FinO does not interact tightly with
the bases or sugars of the RNA, and largely relies on
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Figure 7. Summary of RNase V1 and I cleavage reactions of SLII and
SLIIc. (A) Secondary structures of SLII and SLIIc showing the results
from the RNase cleavage reactions. Large and small black arrowheads
denote strong and weak RNase V1 cleavages, respectively in the
presence of the FinO constructs. Large and small open arrowheads
denote strong and weak RNase I cleavages, respectively in the
presence of FinO. Boxes indicate footprints where FinO protected the
RNAs from RNase V1 cleavage. Dashed boxes indicate areas of pro-
tection from RNase I cleavage by FinO. An area where a ‘V’ resides
indicates enhanced cleavage by RNase I in the presence of the FinO
constructs. (B) Electrostatic potentials at the solvent accessible surface
of FinO33–184, contoured at ±10 kT/e. Approximate surface locations
of the six FinO side-chains known to cross-link to SLII are labeled and
shown with semi-transparent circles.
Nucleic Acids Research, 2011,Vol.39, No. 10 4459electrostatic interactions between the large number of
positively charged residues on the surface of FinO and
the RNA phosphate groups. This is consistent with the
ﬁnding that, while FinO requires its targets to contain a
duplex-single strand junction, the precise sequence of the
RNA target appears to be less critical (11).
While our footprinting and cross-linking data identiﬁed
areas of SLII and SLIIc which are contacted by FinO, and
highlighted which areas of FinO contact SLII, these data
alone do not directly reveal the orientation of the stem–
loop on FinO. In the absence of high resolution structural
information, we chose SAXS to guide our structural
modeling of the FinO–RNA complex. SAXS is a low reso-
lution, solution technique able to provide information on
ﬂexible complexes (36,37) and can be particularly
powerful when applied to restrain the docking of known
structures (21). We used biochemical constraints from the
RNase footprinting data presented here and site-speciﬁc
FinO–RNA cross-linking studies (14) to guide the gener-
ation of a large set of docked test models composed of
FinO45–186 and the tailed SLII duplex. Molecular
dynamics was employed during the docking procedure
to provide conformational ﬂexibility for the single
stranded tails of the RNA. The resulting models were
then ranked based on their ﬁt to experimental SAXS
data for this complex. This procedure distinguished a
cluster of conformationally similar models that ﬁt the
SAXS data much better than the other models. In the
best ﬁt model obtained from this procedure, FinO lies
against the 30 single strand and 30 side of the duplex in a
manner that at once accounts for the RNase protection
A
90°
B
90°
Figure 8. Combining HADDOCK and SAXS to model FinO45–186:
SLII. Pair-wise RMSD cluster analysis was performed on the top 250
models ordered on  
2. Five clusters were obtained using an RMSD
cutoff of 13A ˚ .( A) Model complexes from the best cluster (mean  
2
for nine members, 4.1) are shown in gray. The average structure for this
cluster as calculated using THESEUS is represented with red spheres.
(B) The average structures for all ﬁve clusters are shown superimposed.
The average structure for the best cluster shown in (A) is shown as a
red ribbon, and that of a signiﬁcant structural outlier in white.
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Figure 9. Representative FinO45–186:SLII model. (A) Shown in stereo,
a cartoon representation of one of the individual FinO–SLII complexes
from the cluster analysis. Nucleotides 7, 8 and 34–45, which are pro-
tected from RNase I and VI cleavage upon complex formation, are
shown in red. Side-chains of cross-linking residues Arg121, Lys125,
Arg165 and Lys176 are all within contact distance of the
single-stranded 30-tail. (B) The theoretically calculated small-angle
X-ray scattering curve (black) of the model shown in (A) ﬁts the ex-
perimental data curve (red) with a  
2 of 4.2. Inset, the Guinier plot of
experimental data points 2–36 (s.RG 0.61–1.29), the linear nature of
which indicates a lack of aggregation in the sample.
4460 Nucleic Acids Research, 2011,Vol.39, No. 10patterns as well as site speciﬁc FinO–RNA cross-linking
data. The upper portions of the stem–loop are solvent
exposed and the stem–loop is oriented anti-parallel to
the N-terminal a-helix of FinO. While stem-loop orienta-
tions in other directions may ﬁt the footprint and
cross-link data to varying degrees, only complexes
having the general stem–loop orientation shown in the
clusters (Figure 8B) ﬁt both these data and the SAXS
data. Hence, SAXS allows us to break the ambiguity of
RNA orientation on FinO.
Intriguingly, we also demonstrate that either phosphor-
ylation or oxidation of the 30-nucleotide of SLII abrogates
FinO binding, suggesting that FinO selectively recognizes
the 30-nucleotide of the target RNA in a manner that
requires a free 30-hydroxyl group. This suggests that
primary FinO RNA targets will be found near the
30-terminus of transcripts, as is the case for FinP SLII;
however, stem–loops buried within larger RNAs, such as
SLIIc within traJ mRNA, may be recognized less efﬁcient-
ly. The La protein also binds RNA transcripts in a manner
that relies on the presence of a 30-hydroxyl group (38).
Selective binding of 30-hydroxyl versus 30-phosphate tran-
scripts by La is mediated in part by a conserved aspartic
acid that may select against the negatively charged
30-phosphate. La binding at the 30-end of pol III tran-
scripts protects these RNAs from exonucleolytic degrad-
ation. While FinO also protects FinP against degradation
in vivo, the degradation is catalyzed by the endonuclease
RNase E, and exonucleases such as PNPase and RNase II
are likely not involved (8).
Implications for the molecular mechanism of FinO RNA
chaperone function
FinO45–186 is responsible for stable, high afﬁnity recogni-
tion of its speciﬁc RNA substrates; however, this region is
completely unable to facilitate FinP–traJ interactions.
Instead, the highly ﬂexible N-terminal regions are abso-
lutely essential for this function. These regions do contact
the RNA, as indicated by site-speciﬁc protein–RNA cross-
linking (14). The N-terminal regions likely do not contact
regions of the RNA target outside that bound by
FinO45–186, since the footprints obtained with full-length
FinO and FinO45–186 are identical. We suggest that the
N-terminal region, which adopts an extended conform-
ation in the crystal structure of the free protein, collapses
around the RNA to contact the base of the stem and/or
the 30 single-stranded region. This rearrangement is sup-
ported by in-gel ﬂuorescence resonance energy transfer
(FRET) experiments that suggest that residues 37 and 42
within this region (KWK37 KVKKQK42) come into rela-
tively close contact with the single-stranded tails of an
SLII-like RNA, but not with regions of the duplex close
to the hairpin loop (14). This rearrangement could bring
Trp36, which appears to be the single residue most critical
for RNA annealing and chaperone activity (15), into
contact with the duplex-single-stranded junction, poten-
tially to stack with exposed bases in this region.
Stacking between hydrophobic amino acid side chains
and nucleotide bases are a common feature of protein–
RNA recognition processes, especially for proteins which
recognize substrates containing duplex-single-stranded
junctions (39,40).
Disordered or highly dynamic protein domains are
thought to be a common hallmark of many RNA chaper-
ones, such as hnRNP A1 (41) and HIV nucleocapsid
protein (42). An ‘entropy transfer model’ for chaperone
function has been proposed in which structural disorder
in the unbound chaperone is transferred to the RNA sub-
strate upon binding, increasing the ﬂexibility of the RNA
and aiding in RNA refolding processes (43). Intriguingly,
there appears to be an inverse correlation between the
chaperone activity of FinO mutants and their RNA
binding afﬁnities. FinO45–186, which has no detectable
chaperone activity, binds RNA 20-fold more tightly than
full-length FinO, while FinO26–186, which has a more
modest 10-fold decrease in the rate of RNA strand anneal-
ing, also shows a lesser, 4-fold increase in RNA binding
afﬁnity compared to full-length (15). We suggest that
RNA binding may provide free energy required for
RNA remodeling, consistent with the entropy transfer
model. In this way, FinO45–186 may anchor the initial
binding process and facilitate the subsequent action of
the N-terminal chaperone domain.
FinO deﬁnes a new family of bacterial RNA chaperones
The best studied RNA chaperone in bacterial systems is
Hfq, an Sm domain protein that adopts a hexameric ring
structure and binds AU-rich RNA targets on one side of
the ring (44). Mechanistically, Hfq likely functions differ-
ently than FinO. Whereas Hfq, like FinO, exhibits RNA
annealing activity, it does not exhibit strong RNA strand
exchange activity (45).
Searches of protein sequence databases reveals that the
E. coli protein ProQ, a post-transcriptional regulator of
osmotic stress (46,47), contains a domain with 25%
sequence identity to FinO45–186 (48,49). Intriguingly,
ProQ contains a second domain with similarity to Sm
domain proteins. Thus, ProQ may act as novel,
two-domain chaperone in E. coli. While sequence-based
searches do not reveal other proteins with similarity to
FinO, protein structure similarity searches reveal that
the Neisseria meningitidis protein NMB1681 (PDB code
2HXJ) bears striking similarity to FinO45-186, with add-
itional ﬂexible N- and C-terminal regions. It is therefore
possible that FinO is not a unique RNA chaperone, but
may be a member of a larger family of chaperones that
function in many bacterial species to regulate diverse small
RNA-mediated processes.
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